← Back to Clinical Trials
Recruiting NCT05044832

NCT05044832 Decreasing Emergence Agitation With Personalized Music

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05044832
Status Recruiting
Phase
Sponsor Stanford University
Condition Surgical Procedure, Unspecified
Study Type INTERVENTIONAL
Enrollment 100 participants
Start Date 2021-11-12
Primary Completion 2026-11

Eligibility & Interventions

Sex All sexes
Min Age 3 Years
Max Age 9 Years
Study Type INTERVENTIONAL
Interventions
Personalized Music

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 100 participants in total. It began in 2021-11-12 with a primary completion date of 2026-11.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The purpose of the study is to assess the impact of personalized music on emergence agitation (EA), as measured by Pediatric Anesthesia Emergence Delirium scores in pediatric patients recovering from elective procedures under general anesthesia. Personalized music may help to decrease EA in children undergoing elective surgeries under general anesthesia by decreasing perioperative anxiety and minimizing perceived pain. The study has the potential to improve perioperative care by improving safety, decreasing the need for postoperative pharmacologic and nursing interventions, thereby shortening the time of recovery and improving caregiver satisfaction. Participants participating in this study will be randomly assigned to receive personalized music plus standard of care, or standard of care alone. Those assigned to the music group will receive music in the preoperative holding area as well as in the post-operative care unit.

Eligibility Criteria

Inclusion Criteria * patient ages 3-9 (chosen due to high incidence of emergence delirium and presence of musical memory seen in this age group) * unilateral or bilateral myringotomy procedure, laser treatment for skin lesions, adenoidectomy without tonsillectomy * tonsillectomy with or without adenoidectomy Exclusion Criteria * Chronic intake of any sedative or analgesic medication * Combined surgical procedure not otherwise listed in inclusion criteria * Surgical or anesthetic complications (including use of invasive airway device for myringotomy) * History of significant hearing loss impeding the ability to hear music * Lack of interest in music reported by parents or inability to identify personally meaningful music

Contact & Investigator

Central Contact

Jyoti Bhamidipati, MBBS

✉ jyotib@stanford.edu

📞 650 229 2144

Principal Investigator

R J Ramamurthi, MD

PRINCIPAL INVESTIGATOR

Stanford University

Frequently Asked Questions

Who can join the NCT05044832 clinical trial?

This trial is open to participants of all sexes, aged 3 Years or older, up to 9 Years, studying Surgical Procedure, Unspecified. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05044832 currently recruiting?

Yes, NCT05044832 is actively recruiting participants. Contact the research team at jyotib@stanford.edu for enrollment information.

Where is the NCT05044832 trial being conducted?

This trial is being conducted at Stanford, United States, St Louis, United States.

Who is sponsoring the NCT05044832 clinical trial?

NCT05044832 is sponsored by Stanford University. The principal investigator is R J Ramamurthi, MD at Stanford University. The trial plans to enroll 100 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology